NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,436 | +4.1% | 6,955 | +3.1% | 0.19% | +3.2% |
| Q2 2023 | $680,436 | -2.3% | 6,743 | -10.9% | 0.18% | -5.1% |
| Q1 2023 | $696,624 | +8.3% | 7,572 | +6.8% | 0.20% | +2.1% |
| Q4 2022 | $643,477 | +135.7% | 7,093 | +97.2% | 0.19% | +112.2% |
| Q3 2022 | $273,000 | -11.4% | 3,597 | -1.2% | 0.09% | -10.9% |
| Q2 2022 | $308,000 | -15.2% | 3,640 | -12.0% | 0.10% | -10.6% |
| Q1 2022 | $363,000 | +6.1% | 4,136 | +5.0% | 0.11% | -0.9% |
| Q4 2021 | $342,000 | +25.7% | 3,939 | +18.4% | 0.11% | +14.0% |
| Q3 2021 | $272,000 | -0.7% | 3,326 | +10.7% | 0.10% | -9.1% |
| Q2 2021 | $274,000 | +10.0% | 3,005 | +3.0% | 0.11% | -5.2% |
| Q1 2021 | $249,000 | -0.8% | 2,917 | +9.9% | 0.12% | -6.5% |
| Q4 2020 | $251,000 | +17.3% | 2,655 | +7.9% | 0.12% | -0.8% |
| Q3 2020 | $214,000 | -0.5% | 2,461 | 0.0% | 0.12% | -6.0% |
| Q2 2020 | $215,000 | – | 2,461 | – | 0.13% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |